Home›Companies›Industrial & Robotics›Khaya Biosciences

Khaya Biosciences, Inc.

Develops materials from waste for potential use in packaging, fashion and medical textiles.

Updated Nov 9, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About Khaya Biosciences

Khaya Biosciences is a private company based in Dothan, Alabama, incorporated in 2025 in New York. It has reported $200,000 raised in one offering on Form D since August 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 5, 2026Aug 13, 2026$200,000of $850K target2$100KEquity, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Khaya Biosciences's Form D filed Aug 13, 2026.

GS
Garcia Sebastian
Executive officer and director

Sources

  1. SECKhaya Biosciences, Inc. filing history
  2. CompanyKhaya Biosciences press